Influenza virus-specific neutralizing IgM antibodies persist for a lifetime

Clin Vaccine Immunol. 2014 Nov;21(11):1481-9. doi: 10.1128/CVI.00374-14. Epub 2014 Aug 27.

Abstract

Detection of immunoglobulin M (IgM) antibodies has long been used as an important diagnostic tool for identifying active viral infections, but their relevance in later stages has not been clearly defined in vivo. In this study, we followed the kinetics, longevity, and function of influenza virus-specific IgM antibodies for 2 years following sublethal infection of mice with live mouse-adapted A/PR/8/34 virus or immunization with formalin-inactivated virus. These groups mounted robust protective immune responses and survived lethal challenges with 50 × 50% lethal dose (LD50) mouse-adapted A/PR/8/34 virus 600 days after the primary exposure. Surprisingly, the virus-specific IgM antibodies persisted along with IgG antibodies, and we found a significantly higher number of IgM-positive (IgM(+)) virus-specific plasma cells than IgG(+) plasma cells that persisted for at least 9 months postexposure. The IgM antibodies were functional as they neutralized influenza virus in the presence of complement just as well as IgG antibodies did.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / blood*
  • Complement System Proteins / immunology
  • Disease Models, Animal
  • Female
  • Immunoglobulin M / blood*
  • Influenza A virus / immunology*
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / immunology*
  • Mice, Inbred BALB C
  • Neutralization Tests
  • Orthomyxoviridae Infections / prevention & control*
  • Plasma Cells / immunology
  • Survival Analysis
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Immunoglobulin M
  • Influenza Vaccines
  • Vaccines, Inactivated
  • Complement System Proteins